United States: Spotlight On Upcoming Oral Arguments – January 2019

Tuesday, January 8, 2019

Automotive Body Parts Ass'n v. Ford Global Technologies LLC, No. 18-1613, Courtroom 203

The Automotive Body Parts Association ("ABPA") appeals from an Eastern District of Michigan decision granting summary judgment for Ford.  The district court held that Ford's design patents directed to the exterior of an F-150 truck hood and F-150 headlamp were not invalid under 35 U.S.C. § 171 because the claimed designs are ornamental, not functional. 

ABPA argues that the claimed designs are functional and that the design is dictated by the need for the parts to "mate and match" with the other F-150 parts.  ABPA argues that the claimed designs are necessary to work with the combination of other F-150 parts both when originally sold as part of the F-150 truck and when purchased as a repair/replacement part.  Alternatively, ABPA argues that the authorized sale of the F-150 truck exhausts the patent rights in the claimed designs and creates an implied license allowing the purchaser to repair the F-150 truck by purchasing repair/replacement parts that embody the claimed designs.  In response, Ford contends that there are many ways to design components that will fit on the F-150 truck and work with the other F-150 parts.  Ford argues that the claimed designs are ornamental because there are numerous alternative designs for the hood and headlamp, and therefore, the claimed designs are not the "only possible form" of the articles that could perform the necessary function.  With respect to ABPA's exhaustion argument, Ford argues that the sale of the F-150 truck only exhausts the rights to the specific parts attached to the vehicle purchased by the consumer.  Ford contends that the sale does not impact its rights in new hoods and headlamps that are available for sale as repair/replacement parts. 

Wednesday, January 9, 2019

Prism Technologies LLC v. Sprint Spectrum L.P., No. 18-1108, Courtroom 402

Prism appeals a District of Nebraska decision granting Sprint's request for relief from judgment under Fed. R. Civ. P. 60(b).  This appeal arises as a result of two actions involving Prism and the asserted patents.  In the first action, Prism proceeded to trial against Sprint with a subset of the asserted claims.  A final judgment was entered in favor of Prism in June 2015 and the judgment was upheld on appeal.  In May 2017, Prism filed a motion to enforce the June 2015 judgment.  In the second action, Prism asserted the same claims against T-Mobile but proceeded to trial with a different subset of the asserted claims. On appeal, the Federal Circuit found the claims asserted against T-Mobile invalid under 35 U.S.C. § 101.  While Prism's motion to enforce the 2015 judgment was pending, Sprint moved for relief from Judgment under Fed. R. Civ. P. 60(b) in light of the T-Mobile decision.  The district court granted Sprint's motion finding that the T-Mobile decision collaterally estops Prism from recovering from Sprint.

Prisms contends that Sprint cannot establish exceptional circumstances to justify setting aside the June 2015 judgment when it intentionally decided not to pursue an invalidity defense at trial.  Moreover, Prism argues that the T-Mobile decision applies only to the claims asserted at trial in that action, not the claims asserted at trial in the Sprint action.  Conversely, Sprint argues that the intervening invalidity decision constitutes an "exceptional circumstance" that justifies setting aside the judgment under Fed. R. Civ. P. 60(b).  Sprint contends that this is true even though it did not challenge validity at trial.  Sprint further argues that the claims invalidated in the T-Mobile action include those asserted against Sprint.  Sprint asserts that Prism asserted the same set of claims against both Sprint and T-Mobile and that the invalidity decision applies to all of the asserted claims, not just the subset that proceeded to trial. 

Thursday, January 10, 2019

Cleveland Clinic Foundation v. True Health Diagnostics LLC, No. 18-1218, Courtroom 201

Cleveland Clinic Foundation ("CCF") appeals from an Eastern District of Virginia decision granting True Health's 12(b)(6) motion to dismiss.  The patents at issue are directed to laboratory methods for detecting myeloperoxidase in the blood of patients with cardiovascular disease.  The district court held that the patents were invalid under 35 U.S.C. § 101 as directed to a patent-ineligible law of nature.

CCF argues that the district court erred in granting True Health's motion because there were many material facts in dispute, which the district court acknowledged, and CCF pled sufficient facts to establish patent eligibility.  CCF further argues that the district court incorrectly applied the two-step Alice test because it ignored evidence in the record about the state of the art and refused to acknowledge the science behind the groundbreaking discoveries that led to the claimed methods.  True Health argues that any factual disputes were immaterial because any factual issues relevant to the Alice test were resolved by the patentees' admissions in the specification and prosecution history.  True Health further argues that the district court correctly applied the Alice test and that the claims are directed to the natural correlation between atherosclerotic cardiovascular disease and elevated myeloperoxidase levels.

Friday, January 11, 2019

In Re Siny Corp., No. 18-1077, Courtroom 402

Siny appeals the TTAB's refusal to register the mark CASALANA.  Siny filed the application based on use in commerce under 15 U.S.C. § 1051(a).  In connection with their application, Siny submitted a print-out of a webpage as their specimen of use.  The webpage included the mark below an image of a product and included the text "for sales information" followed by a telephone number and an e-mail address which would allow potential customers to place an order.  The TTAB found that the specimen of use submitted by Siny was merely advertising material and did not constitute a "display associated with the goods."

Siny argues that the TTAB ignored the broad definition of "use in commerce" and concentrated on specific criteria, such as lack of pricing and shipping information on the specimen.  Moreover, Siny argues that the Board's requirement that a specimen of use have the capability to independently effectuate a sale is unsupported by the plain language of the Trademark Act and ignores Federal Circuit precedent that rejected a bright line rule for specimen of use requirements.  In response, the PTO argues that the TTAB did not apply a bright line rule and maintains that Siny's specimen is merely advertising that does not show use of the CASALANA mark in commerce.  The PTO argues that a web printout can satisfy the requirement if the printout is a point of sale display, but Siny's printout does not satisfy that requirement. 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
22 Jan 2019, Webinar, Washington, DC, United States

As part of Strafford Publications’ webinar series, Finnegan partners Shana Cyr and Mark Feldstein will provide essential updates on FDA practice and patent law relating to biologics and biosimilars.

27 Jan 2019, Other, Washington, DC, United States

Finnegan is a sponsor of the Association of Corporate Patent Counsel Winter Meeting. Finnegan partner Erika Arner will join the panel discussion “PTAB Review & Litigation.”

27 Jan 2019, Other, Florida, United States

Finnegan is a sponsor of the Association of Corporate Patent Counsel Winter Meeting. Finnegan partner Erika Arner will join the panel discussion “PTAB Review & Litigation.

 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions